Connect with us

Health

CDC warns of ‘dual mutant’ flu strain that could evade antiviral drugs: ‘Need to closely monitor’

Published

on

CDC warns of ‘dual mutant’ flu strain that could evade antiviral drugs: ‘Need to closely monitor’

Join Fox News for access to this content

Plus special access to select articles and other premium content with your account – free of charge.

By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

Please enter a valid email address.

Having trouble? Click here.

A new “dual mutant” strain of H1N1 influenza could pose a threat in the U.S., according to the Centers for Disease Control and Prevention (CDC).

Details about the two strains, I223V and S247N, were published in the journal Emerging Infectious Diseases, which is published by the CDC.  

Advertisement

At least two cases of the flu mutations have been confirmed in humans in the U.S., the agency announced on Wednesday.

COVID-FLU COMBO VACCINE SHOWS ‘POSITIVE’ RESULTS IN PHASE 3 TRIALS, MODERNA SAYS: A ‘TWO-FOR’ OPTION

The researchers identified a total of 101 samples of the “dual mutant” virus.

The concern is that these strains of flu have shown to be resistant to the antiviral medications that are typically used to treat the virus — notably Tamiflu (oseltamivir), the common flu medication from Switzerland-based Roche.

A new “dual mutant” strain of H1N1 influenza could pose a threat in the U.S., according to the Centers for Disease Control and Prevention. (iStock)

Advertisement

“The dual mutants that we tested retained susceptibility to other approved influenza antiviral drugs, including baloxavir,” the researchers wrote in the study findings.

CDC, WEBMD GIVE UPDATE ON CURRENT BIRD FLU OUTBREAK: ‘BE ALERT, NOT ALARMED’

“Our study highlights the need to closely monitor the evolution of dual mutants, because additional changes may further affect susceptibility to antiviral drugs or provide a competitive advantage over circulating wild-type viruses.”

The strains have been detected in 15 countries across five continents, but are mostly prevalent in Europe, the study found.

“The dual mutants that we tested retained susceptibility to other approved influenza antiviral drugs, including baloxavir,” the researchers wrote. (iStock)

Advertisement

The researchers determined that the mutations have been circulating globally since May 2023.

I223V and S247N were first tested by Hong Kong scientists, who published their findings in The Lancet Microbe in March 2024. 

Those researchers also found that the mutant strains lessened the effectiveness of Tamiflu.

                                            

Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and a Fox News medical contributor, said it is “highly unusual” to see an influenza A strain (H1N1, which is a distant cousin of the Spanish flu, he noted) spreading throughout southern U.S. states at this time of year. 

Advertisement

People who contract the flu can take antiviral medications to ease symptoms, the CDC stated, which is most important for high-risk patients. (iStock)

“Flu season is usually over by March,” Siegel told Fox News Digital. “Flu doesn’t spread as easily in hot, humid weather.”

He added, “This mutation worries me because the use of Tamiflu — especially in high-risk groups and the elderly — is really helpful at decreasing severity, and it looks like the reaction to it is less.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The doctor said he would still recommend using the drug, however, because it has some impact — “or consider other anti-flu drugs.”

Advertisement

Siegel also advised a vaccine booster for the elderly or those in high-risk groups.

The CDC recommends that everyone 6 months and older receives an annual vaccine during heightened flu spread. (iStock)

So far this season, the CDC estimates that there have been at least 35 million illnesses, 390,000 hospitalizations and 24,000 deaths from the flu, as published on the agency’s website.

The CDC recommends that everyone 6 months and older receives an annual vaccine during heightened flu spread.

For more Health articles, visit www.foxnews/health 

Advertisement

People who contract the flu can take antiviral medications to ease symptoms, the CDC stated, which is most important for high-risk patients.

Fox News Digital reached out to Roche and to the CDC for additional comment.

Health

Popular fruit may help protect your skin from the sun, new study suggests

Published

on

Popular fruit may help protect your skin from the sun, new study suggests

NEWYou can now listen to Fox News articles!

The benefits of grapes could go beyond providing a healthy snack.

According to a study published in the journal ACS Nutrition Science, regular grape consumption can change how the genes behave, giving the skin an added defense system against sun damage.

The research, led by scientists at Western New England University, suggests that grapes could trigger changes in DNA.

EATING A COMMON VITAMIN-C PACKED FRUIT MIGHT TOTALLY TRANSFORM SKIN, STUDY FINDS

Advertisement

Researchers tracked a group of volunteers who first followed a restricted diet for two weeks to clear their systems, according to a press release.

Then, for the next two weeks, they ate the equivalent of three daily servings of whole grapes, provided in a concentrated, freeze-dried powder form.

Regular grape consumption can change how the genes behave, giving the skin an added defense system against sun damage, research suggests. (iStock)

The scientists took small skin samples before and after the grape diet, testing them both under normal conditions and after exposing them to low doses of ultraviolet (UV) light from the sun.

At the start of the study, each volunteer had their own pattern of gene activity. However, these patterns shifted noticeably after they ate grapes, after they were exposed to UV light, and when the grape-eating was combined with UV exposure.

Advertisement

SUNLIGHT EXPOSURE CAN POSE LIFE-CHANGING HEALTH BENEFITS, EXPERT SAYS

While everyone’s individual genetic responses were unique, grape consumption changed gene expression across all participants.

When skin is exposed to UV rays, it normally creates a chemical called malondialdehyde, which is a warning sign of cellular damage. After eating grapes, the volunteers showed significantly less of this damaging chemical, the study found.

When skin is exposed to UV rays, it normally creates a chemical called malondialdehyde, which is a warning sign of cellular damage. (iStock)

“We are now certain that grapes act as a superfood and mediate a nutrigenomic response in humans,” John Pezzuto, PhD, professor and dean of the College of Pharmacy and Health Sciences at Western New England University, said in the press release.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“We observed this with the largest organ of the body, the skin. The changes in gene expression indicated improvements in skin health.”

CLICK HERE FOR MORE HEALTH STORIES

Pezzuto also noted that the benefits likely don’t stop at the skin.

“Beyond skin, it is nearly certain that grape consumption affects gene expression in other somatic tissues of the body, such as the liver, muscles, kidney and even brain,” he said.

Advertisement

“The changes in gene expression indicated improvements in skin health,” the researcher said. (iStock)

A major limitation of the study is its very small sample size, as usable, complete RNA sequencing data was successfully obtained from only four female participants, the researchers noted.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Additionally, all four of these women shared a very similar skin type and background, meaning the genetic findings may not apply to a broader, more diverse population.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

The researchers also emphasized that regular grape consumption cannot replace traditional sunscreen or sun-safe habits, and that the study relied on a highly concentrated grape powder rather than occasional, casual snacking.

Continue Reading

Health

Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say

Published

on

Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say

NEWYou can now listen to Fox News articles!

An investigational dementia drug may also ease alcohol withdrawal by calming the brain inflammation linked to addiction and relapse.

That’s according to researchers at the University of Kentucky, who studied an experimental medication called MW150 that targets a brain inflammation pathway known as p38α MAPK.

The drug, which has not yet been approved, is designed to treat mild to moderate Alzheimer’s disease.

ALCOHOL DEATHS HAVE MORE THAN DOUBLED IN RECENT YEARS, ESPECIALLY AMONG WOMEN

Advertisement

Scientists believe neuroinflammation may contribute to relapse risk and long-term neurological damage in people with alcohol use disorder.

In laboratory and animal-model experiments, MW150 was found to reduce certain inflammatory markers during alcohol withdrawal.

An investigational dementia drug may also ease alcohol withdrawal by calming the brain inflammation linked to addiction and relapse. (iStock)

The work, which was published in the journal Alcohol, came from the University of Kentucky’s Sanders-Brown Center on Aging, led by neuroinflammation researcher Linda Van Eldik.

ALCOHOL POSES THESE 8 RISKS TO OLDER ADULTS, EXPERTS WARN

Advertisement

Caleb Bailey, Ph.D., co-author of the study and a researcher in Van Eldik’s lab, said the study provides “biological plausibility” that MW150 could mitigate neuroinflammation arising from alcohol withdrawal.

Alcohol use disorder is difficult to treat because of high relapse rates, especially during withdrawal, according to Bailey.

Alcohol use disorder is difficult to treat because of high relapse rates, especially during withdrawal, according to the researchers. (iStock)

“If follow-up experiments reveal similar anti-inflammatory effects of MW150 in animal models of alcohol use disorder, it would provide a strong rationale for development of MW150 as a treatment for those struggling with chronic alcohol relapse due to alcohol withdrawal,” he told Fox News Digital.

‘I”M A NEUROSURGEON — HERE’S WHAT ALCOHOL DOES TO THE BODY’

Advertisement

Along with a related drug called Neflamapimod, MW150 is already being investigated in clinical trials as a potential therapy for dementia and other neurodegenerative conditions, the researchers noted.

“That gives this work added significance,” Bailey said. “Because these compounds are already further along in development for other neurological diseases, it raises the possibility that they could someday be repurposed more efficiently for alcohol-related conditions if future studies continue to show promise.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

There were some important caveats to the research, including that it was conducted in cell culture and animal models.

“Because they are ‘dish’-based models, they provide limited information regarding what happens in the full organism – or even the full brain for that matter,” Bailey said.

Advertisement

MW150, along with a related drug called Neflamapimod, is already being investigated in clinical trials as a potential therapy for dementia and other neurodegenerative conditions. (iStock)

“A series of follow-up studies in living animals is required to more fully understand how future MW150 treatment in alcohol use and withdrawal affects systemic health and/or alcohol consumption.”

CLICK HERE FOR MORE HEALTH STORIES

Dr. Amy Swift, deputy chief medical officer at Silver Hill Hospital in Connecticut, was not involved in the study but shared her reactions to the findings.

“Although detoxification using tapering doses of medication has long been considered the evidence-based first step in treating alcohol use disorder, its impact on the long-term trajectory of a person’s drinking behavior has been limited,” she told Fox News Digital.

Advertisement

“Minimizing alcohol consumption … is the best strategy for staying healthy.”

“Put simply, detoxification does not treat alcohol use disorder itself; rather, it prevents the potentially fatal complications of alcohol withdrawal.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Adding supportive medications — especially those intended to improve overall brain health — could address an important gap in early treatment of detoxification, according to Swift.

“It is worthwhile to investigate whether reducing neuroinflammation could improve a patient’s ability to engage in treatment earlier in recovery and, in turn, meaningfully alter their long-term relationship with alcohol,” an expert said. (iStock)

Advertisement

“Given the profound inflammatory effects alcohol has across multiple organ systems, it is worthwhile to investigate whether reducing neuroinflammation could improve a patient’s ability to engage in treatment earlier in recovery and, in turn, meaningfully alter their long-term relationship with alcohol,” she added.

Bailey emphasized that no amount of alcohol consumption is good from a physical health standpoint.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“We don’t currently have robust pharmacological treatments to mitigate damage caused by chronic alcohol consumption,” he said. “Minimizing alcohol consumption, therefore, is the best strategy for staying healthy.”

As the MW150 compound continues to be studied for dementia patients, Bailey saud, “information regarding the interaction between these drugs and alcohol — for better or for worse — will be important for patient outcomes.”

Advertisement

Continue Reading

Health

One type of sitting may pose greater dementia risk than another, study suggests

Published

on

One type of sitting may pose greater dementia risk than another, study suggests

NEWYou can now listen to Fox News articles!

For years, researchers have believed prolonged sitting could raise dementia risk — but new findings suggest the type of sitting may matter more than previously thought.

The research, which was published in the American Journal of Preventive Medicine in March, found that replacing mentally passive sedentary behavior with mentally active sedentary behavior was associated with a significant reduction in dementia risk.

Mentally active sedentary behaviors could include reading, office work and other activities that keep the brain engaged while sitting, while mentally passive behaviors may include watching television or other low-engagement screen activities.

‘I’M A NEUROLOGIST — HERE’S WHY DEMENTIA IS RISING AND HOW TO REDUCE YOUR RISK’

Advertisement

To gather the findings, Swedish researchers analyzed data from more than 20,000 adults between ages 35 and 64 who were tracked over a 19-year period, between 1997 and 2016, according to a press release.

Participants answered questions about their sitting habits, physical activity and other lifestyle behaviors, while dementia diagnoses were identified using Swedish health and death records.

Researchers emphasized that how people use their brains while sitting may matter more than previously understood. (iStock)

Mentally active sedentary behavior was associated with “a significant reduction in dementia risk” compared to more passive sitting activities.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

Although the study was based in Sweden, the release said the findings “are likely generalizable to a wider global population” and could help “inform public health guidelines and preventive strategies to reduce dementia.”

In a statement, lead researcher Dr. Mats Hallgren of Sweden’s Karolinska Institute said the study highlighted major distinctions between passive and mentally engaging sedentary habits when it comes to brain health.

The research tracked more than 20,000 adults over nearly two decades to examine links between sitting habits and dementia. (iStock)

“While all sitting involves minimal energy expenditure, it may be differentiated by the level of brain activity,” said Hallgren.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“How we use our brains while we are sitting appears to be a crucial determinant of future cognitive functioning and, as we have shown, may predict dementia onset.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Sedentary behavior is a “ubiquitous but modifiable risk factor for many health conditions, including dementia,” according to the researcher.

“Our study adds the observation that not all sedentary behaviors are equivalent; some may increase the risk of dementia, while others may be protective,” he added. “It is important to remain physically active as we age, but also mentally active — especially when we are sitting.”

The findings suggest not all sitting behaviors are equal when it comes to protecting long-term brain health. (iStock)

Advertisement

The CDC projects that by 2060, nearly 14 million American adults will have Alzheimer’s disease.

One recent study published by the Alzheimer’s Association found that a person’s biological age may be tied to dementia risk.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Researchers also recently found that a higher intake of unprocessed meat may protect against dementia in older people who have a variant of a certain gene.

Advertisement
Continue Reading
Advertisement

Trending